Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector serotype Anc80 containing the truncated human ATP7B gene under the control of the human alpha-1 antitrypsin promoter

EU orphan designation number: EU/3/17/1898   
Active ingredient: Adeno-associated viral vector serotype Anc80 containing the truncated human ATP7B gene under the control of the human alpha-1 antitrypsin promoter
Indication: Treatment of Wilson's disease
Sponsor: Vivet Therapeutics SAS
29 rue Tronchet, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/08/2017 Orphan designation EMA/OD/084/17 (2017)5907 of 23/08/2017
13/07/2018 Change of name and/or address of sponsor